[1]常浩宇,赵改花,田龙,等.功能磁共振成像在前列腺癌放疗中应用进展[J].肿瘤影像学,2023,32(2):194-199.
CHANG HY,ZHAO GH,TIAN L,et al.Application progress of functional magnetic resonance imaging in radiotherapy for prostate cancer[J].Oncoradiology,2023,32(2):194-199.
[2]田龙,范学武,许蕊,等.对比T2WI与T2*WI用于前列腺癌放射治疗计划的效果[J].中国介入影像与治疗学,2022,19(4):239-244.
TIAN L,FAN XW,XU R,et al.Comparison on T2WI and T2*WI for radiotherapy planning of prostate cancer[J].Chinese Journal of Interventional Imaging and Therapy,2022,19(4):239-244.
[3]闫洁诚,田龙,胡逸民.膀胱癌放疗中两种图像引导方法校准精度比较[J].北京生物医学工程,2021,40(3):303-308.
YAN JC,TIAN L,HU YM,et al.Comparing the calibration accuracy of two image guided methods in bladder cancer radiotherapy[J].Beijing Biomedical Engineering,2021,40(3):303-308.
[4]宋晓,田龙,武雪亮,等.锥形束CT预测前列腺癌靶区运动的研究[J].实用临床医药杂志,2021,25(13):24-27,31.
SONG X,TIAN L,WU XL,et al.Study on cone beam CT in predicting the movement of prostate cancer target[J].Journal of Clinical Medicine in Practice,2021,25(13):24-27,31.
[5]冀鑫,李珺,庞永鹏,等.前列腺癌影像引导放疗中电子射野影像装置和经会阴超声实时位置验证方法比较[J].肿瘤学杂志,2023,29(1):48-53.
JI X,LI J,PANG YP,et al.Comparison of real time position verification of electronic portal imaging device versus trans-perineal ultrasound in image guided radiotherapy for prostate cancer[J].Journal of Chinese Oncology,2023,29(1):48-53.
[6]张旺,刘肖,杨海芳,等.基于MRI的前列腺癌放疗中标志物手动辨识与定位评价[J].国际放射医学核医学杂志,2022,46(12):724-729.
ZHANG W,LIU X,YANG HF,et al.Manual identification and localization evaluation of marker in prostate cancer radiotherapy based on magnetic resonance imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2022,46(12):724-729.
[7]田龙,席强,赵鑫,等.膀胱癌图像引导放疗中基于软组织灰度值与基于内植标记物的锥形束CT校准比较[J].中国医学物理学杂志,2018,35(1):31-35.
TIAN L,XI Q,ZHAO X,et al.Comparison of cone beam computed tomography calibrations based on soft tissue grey value and implanted markers in image-guided radiotherapy for bladder cancer[J].Chinese Journal of Medical Physics,2018,35(1):31-35.
[8]赵鑫,田龙,席强.利用kV级CBCT识别标记物研究[J].中国医疗设备,2019,34(3):41-44.
ZHAO X,TIAN L,XI Q.Study on Marker Recognition Using kV CBCT[J].China Medical Devices,2019,34(3):41-44.
[9]张静,范学武,田龙,等.基准标志物在前列腺癌图像引导放疗中的应用[J].中国医学物理学杂志,2023,40(4):397-402.
ZHANG J,FAN XW,TIAN L,et al.Application of fiducial marker in image-guided radiotherapy of prostate cancer[J].Chinese Journal of Medical Physics,2023,40(4):397-402.
[10]何尧林,贺秋冬.水凝胶在局限期前列腺癌放疗中的研究进展[J].中华放射肿瘤学杂志,2018,27(8):789-792.
HE YL,HE QD.Research progress in hydrogel in radiotherapy of localized prostate cancer[J].Chinese Journal of Radiation Oncology,2018,27(8):789-792.
[11]杨烨,侯彦杰,薛少军,等.前列腺癌放疗患者植入水凝胶后对直肠保护作用的Meta分析[J].中华放射医学与防护杂志,2021,41(6):436-443.
YANG Y,HOU YJ,XUE SJ,et al.The protective effects of hydrogel implantation in prostate cancer patients for radiotherapy:a Meta-analysis[J].Chinese Journal of Radiological Medicine and Protection,2021,41(6):436-443.
[12]杨烨,侯彦杰,李险峰.水凝胶在前列腺癌和宫颈癌放疗中对直肠的保护[J].中华放射医学与防护杂志,2020,40(9):728-732.
YANG Y,HOU YJ,LI XF,et al.Protection of hydrogel for rectum in radiotherapy of prostate cancer and cervical cancer[J].Chinese Journal of Radiological Medicine and Protection,2020,40(9):728-732.
[13]肖应.局限性前列腺癌SABR-VMAT的FF和FFF模式治疗的剂量学比较[J].实用癌症杂志,2017,32(9):1557-1560.
XIAO Y.Comparison the dose distribution of VMAT-SABR with flattening filter (FF) and flattening filter-free (FFF) treatment plans for localized prostate cancer[J].The Practical Journal of Cancer,2017,32(9):1557-1560.
[14]高汉晶,陶振,王欢欢,等.射波刀治疗前列腺癌初步临床观察[J].中华放射医学与防护杂志,2019,39(6):415-421.
GAO HJ,TAO Z,WANG HH,et al.Preliminary clinical study on treatment of prostate cancer with Cyber-Knife[J].Chinese Journal of Radiological Medicine and Protection,2019,39(6):415-421.
[15]IOCOLANO M,BLANKSBURG S,CARPENTER T,et al.Prostate fiducial marker placement in patients on anticoagulation:feasibility prior to prostate SBRT[J].Front Oncol,2020,27(10):203.
[16]FISCHER-VALUCK BW,CHUNDURY A,GAY H,et al.Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer:Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall[J].Pract Radiat Oncol,2017,7(3):195-202.
[17]HWANG ME,MAYEDA M,LIZ M,et al.Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer:toxicity profile and early oncologic outcomes[J].Radiat Oncol,2019,14(1):136.
[18]CHAO M,HO H,CHAN Y,et al.Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy[J].BJU Int,2018,122(3):427-433.